[HTML][HTML] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
A Afshar-Oromieh, E Avtzi, FL Giesel… - European journal of …, 2015 - Springer
Purpose Since the introduction of positron emission tomography (PET) imaging with 68 Ga-PSMA-HBED-CC
(= 68 Ga-DKFZ-PSMA-11), this method has been regarded as a significant …
(= 68 Ga-DKFZ-PSMA-11), this method has been regarded as a significant …
[HTML][HTML] Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
A Afshar-Oromieh, CM Zechmann, A Malcher… - European journal of …, 2014 - Springer
Purpose Positron emission tomography (PET) with choline tracers has found widespread use
for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in …
for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in …
PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-labeled PSMA-617
…, M Bronzel, A Afshar-Oromieh… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is an excellent target for radionuclide therapy
of metastasized castration-resistant prostate cancer (mCRPC). Besides high affinity and long …
of metastasized castration-resistant prostate cancer (mCRPC). Besides high affinity and long …
Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer
…, U Bauder-Wüst, A Afshar-Oromieh… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Despite many advances in the past years, the treatment of metastatic prostate cancer still
remains challenging. In recent years, prostate-specific membrane antigen (PSMA) inhibitors …
remains challenging. In recent years, prostate-specific membrane antigen (PSMA) inhibitors …
[HTML][HTML] Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
A Afshar-Oromieh, T Holland-Letz, FL Giesel… - European journal of …, 2017 - Springer
Purpose Since the clinical introduction of 68 Ga-PSMA-11 PET/CT, this imaging method has
rapidly spread and is now regarded as a significant step forward in the diagnosis of …
rapidly spread and is now regarded as a significant step forward in the diagnosis of …
[HTML][HTML] Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
…, U Hennrich, M Eisenhut, A Afshar-Oromieh… - Pharmaceuticals, 2014 - mdpi.com
… Ali Afshar-Oromieh gave scientific advice for the development of the GMP-compliant automated
synthesis. Uwe Haberkorn gave scientific advice for the design of preclinical experiments…
synthesis. Uwe Haberkorn gave scientific advice for the design of preclinical experiments…
[HTML][HTML] Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
CM Zechmann, A Afshar-Oromieh, T Armor… - European journal of …, 2014 - Springer
Introduction Since the prostate-specific membrane antigen (PSMA) is frequently over-expressed
in prostate cancer (PCa) several PSMA-targeting molecules are under development to …
in prostate cancer (PCa) several PSMA-targeting molecules are under development to …
The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor …
A Afshar-Oromieh, H Hetzheim… - Journal of Nuclear …, 2015 - Soc Nuclear Med
PET imaging with the prostate-specific membrane antigen (PSMA)–targeted radioligand 68
Ga-PSMA-11 is regarded as a significant step forward in the diagnosis of prostate cancer (…
Ga-PSMA-11 is regarded as a significant step forward in the diagnosis of prostate cancer (…
Performance characteristics of the biograph vision quadra PET/CT system with a long axial field of view using the NEMA NU 2-2018 standard
…, H Sari, M Fürstner, A Afshar-Oromieh… - Journal of nuclear …, 2022 - Soc Nuclear Med
Our purpose was to evaluate the performance of the Biograph Vision Quadra PET/CT
system. This new system is based on the Biograph Vision 600, using the same silicon …
system. This new system is based on the Biograph Vision 600, using the same silicon …
[HTML][HTML] Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision …
Purpose To investigate the performance of the new long axial field-of-view (LAFOV) Biograph
Vision Quadra PET/CT and a standard axial field-of-view (SAFOV) Biograph Vision 600 …
Vision Quadra PET/CT and a standard axial field-of-view (SAFOV) Biograph Vision 600 …